EC Number   |
Title |
Organism |
|---|
   3.4.22.27 | 2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors |
Homo sapiens |
| 3.4.22.27 | 4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important |
Homo sapiens |
| 3.4.22.27 | 4-Amino-2-cyanopyrimidines: novel scaffold for nonpeptidic cathepsin S inhibitors |
Homo sapiens |
| 3.4.22.27 | 6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors |
Homo sapiens |
| 3.4.22.27 | A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen |
Oryctolagus cuniculus |
| 3.4.22.27 | A novel class of nonpeptidic biaryl inhibitors of human cathepsin K |
Homo sapiens |
| 3.4.22.27 | Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases |
Bos taurus |
| 3.4.22.27 | Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis |
Homo sapiens |
| 3.4.22.27 | Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease |
Mus musculus |
| 3.4.22.27 | Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: optimization of P1 and N-aryl |
Mus musculus |
